CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Charles River Laboratories International, Inc., based in Wilmington, Massachusetts, is a leading provider of critical research tools and integrated support services that enable innovative and efficient drug discovery and development. Charles River is the global leader in providing the animal research models required in research and development for new drugs, devices and therapies and has been in this business for more than 50 years. The Company offers a wide array of services that enable its customers to reduce costs in the discovery, early-stage development and safe manufacture of new therapies.
- 🔗 Charles River Laboratories International, Inc. Raises $224 Million In Initial Public Offering of Common Stock | Charles River Laboratories International, Inc.
- 🔗 Charles River Announces Share Distribution by Investor Group | Charles River Laboratories International, Inc.
- 🔗 Charles River Laboratories International (NYSE:CRL) - Stock Analysis - Simply Wall St
- 🔗 Investor Overview | Charles River Laboratories International, Inc.
- 🔗 Charles River Laboratories International, Inc Stock Price Today | NYSE: CRL Live - Investing.com
Investors
Not disclosed in the source filing. Form D filings do not list investors — StreetZero surfaces them from news where available.
Key highlights
- Global leader in animal research models for over 50 years
- Serves pharmaceutical, biotech, government and academic clients
- Announced $1B equity buyback program
- Partners on cell therapy testing collaborations
- Reports strong revenue performance versus analyst expectations
Ask StreetZero about CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Put our AI to work on this deal.
Similar companies
Other Public Equity (NYSE) deals, ranked by Signal.
Source document & SEC filing
The source SEC filing and the cached document are available to members only. Sign in to view and download them.
Sign in to view the filing Create free account